x
ServiziMenu principaleHome
You are here: Home > Events > Past events > 2012 > 5th Masterclass in Oncology Nursing
Print

5th Masterclass in Oncology Nursing

Not eligible for ESCO credits

17.03.2012  -  22.03.2012

Ermatingen, Switzerland

MASTERCLASS

Nursing

Description

Chairs: A. Margulies, CH - S. Faithfull, UK
Scientific Coordinators: L. Sharp, SE


The Masterclass in Oncology Nursing programme is designed for advanced oncology nurses as a multi-professional joint event. Five intensive days of full immersion in up-to-date oncology will create a collective spirit of teaching and learning to improving clinical skills and patient care.

Nursing sessions are specific nursing-oriented sessions exploring specialist practice skills such as advanced assessment, decision making, communication skills, complex symptom management, care of the older patient, psychosocial consequences of cancer therapy.
Other sessions will provide the forum for  reviewing and understanding the growing evidence base for nursing interventions and reflect on participant’s role in clinical leadership.

In joint Clinical sessions, nurses will, together with physicians, update their clinical knowledge about the latest issues for the management of various cancers, with an international faculty of experts.

Special joint sessions in symptom management, supportive care and palliative care will be supported by workshops and coaching to explore nursing practice in these speciality areas.

Practical training will be offered in smaller group optional sessions and coaching groups  focusing on skills required for the management of active therapy and follow up. 


AIMS AND OBJECTIVES
The Masterclass aims to prepare oncology nurses for future senior roles and enhance their clinical knowledge in the management of the cancer patient during all phases of the cancer journey. Following completion of the course nurses will be able to use evidence based knowledge in effective symptom management and interventions with the aim to improve patient experience, symptom management and care.

Learning outcomes:
• Understand new developments in oncology disease management.
• Recognise and describe acute and late adverse effects of cancer and its treatment.
• Identify complex patient needs across the diagnostic and oncology treatment trajectory.
• Demonstrate advanced communication skills in managing oncology nursing care.
• Critically appraise the evidence for cancer symptom management and intervention.
• Reflect on theoretical underpinnings of decision making .
• Describe the role of the advanced oncology nurse in leading clinical nursing care.


TEACHING FORMAT
The Masterclass offers plenary lectures regarding state-of-the-art clinical evaluation and treatments with reference to clinical guidelines and which will include notes and resources. Participants will be coached within small groups and discuss personal development plans with tutors in the faculty. Skills based clinical sessions will include simulation and role play and participants must be prepared to join in.
All participants will reside at the course venue and participation in the nursing sessions is compulsory throughout the course.
The Masterclass will be entirely in English and fluency in English is necessary for admission.
Participants of the Masterclass in Nursing Oncology will attend selected medical sessions whilst the advanced communication skills will be attended only by nurses.
Clinical case studies, submitted prior to the course, will be a requirement for all participants. The faculty will evaluate which case studies will be presented for group discussion. 


THE MASTERCLASS IS:
• A 5-day residential educational event
• Full immersion
• Clinically-oriented
• Multidisciplinary
• An international faculty of top experts delivering advanced concept

General information


ORGANISING SECRETARIAT
For further information:
eons.secretariat@cancernurse.eu
European Oncology Nursing Society, EONS Secretariat
Att. Rudi Brike
E. Mounierlaan 83
1200 Brussels, Belgium
Phone +32 2 779 9923, Fax +32 2 779 9937

 

Faculty list


FACULTY (as of Juanuary 2012)
A. Albini, IRCCS MultiMedica, Milan, IT
A. Arber, Faculty of Health and Medical Sciences, University of Surrey, Guilford, UK
J. Bernier, Genolier Swiss Medical Network, Department of Radiotherapy, Genolier, CH
T. Brodowicz, AKH Wien, Vienna, AT
G. Cavaletti, Bicocca University, Department of Neuroscience and Biomedical Technologies, Milan, IT
G. Curigliano, European Institute of Oncology, Div. of Medical Oncology, Milan, IT
A. Dietz, University of Leipzig, Department of Otolaryngology, Leipzig, DE
S. Faithfull, Faculty of Health and Medical Sciences, University of Surrey, Guilford, UK
C. Faivre-Finn, Christie Hospital NHS Foundation Trust, Department of Clinical Oncology, Manchester, UK
W. Gatzemeier, Humanitas Clinical Institute, Breast Unit, Rozzano, IT
M. Ghielmini, Oncology Institute of Southern Switzerland, Division of Medical Oncology, Bellinzona, CH
A. Hoy, Consultant in Palliative Medicine, Lead for Advanced Communication Skills SWSH, Epsom, UK
K.H. Köhne, Klinikum Oldenburg, Klinik für Onkologie und Hämatologie, Oldenburg, DE
A. Margulies, Clinical Oncology Nurse, EONS Executive Board Member, Zurich, CH
O. Pagani, Oncology Institute of Southern Switzerland (IOSI), Department
N. Pavlidis, University of Ioannina, Division of Medical Oncology, Ioannina, GR
G.J. Poston, Aintree University Hospital, Dept. of Surgery, Liverpool, UK
G. Pruneri, European Institute of Oncology, Department of Pathology, and Milan University, Milan, IT
K. Redmond, Cancer World Magazine, Lugano, CH
D. Schrijvers, Ziekenhuisnetwerk Antwerpen-Middelheim, Department of
Haemato-Oncology, Antwerp, BE
S. Segaert, University Hospital Sint-Rafaël, Dermatology Department, Leuven, BE
C. Sessa, Oncology Institute of Southern Switzerland, Division of Medical Oncology, Bellinzona, CH
L. Sharp, Karolinska University Hospital, Section for Nursing, Stockholm, SE
R.A. Stahel, University Hospital Zurich, Clinic and Policlinic for Oncology, Zurich, CH
E. Van Cutsem, University Hospital Gasthuisberg, Digestive Oncology Unit, Leuven, BE
J.B. Vermorken, University Hospital Antwerp, Department of Oncology, Edegem, BE
W. Weder, University Hospital Zurich, Division of Thoracic Surgery, Zurich, CH
E. Von Muilekom, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital,
Amsterdam, NL
M. Wells, University of Dundee, Dundee, UK

Programme

17 March

 

Participants' arrival, airport transfers, registration

  14:30

Greetings and introduction to Masterclass in Oncology Nursing:
Aims and objectives 
A. Margulies, CH - S. Faithfull, UK                
  15:00

Group introduction
A. Margulies, CH - S. Faithfull, UK - Participants 

  15:30

Role development: Advanced oncology nursing practice 
S. Faithfull, UK  

 16:15

Developing the evidence base for oncology nursing practice 
L. Sharp, SE 

 17:00

Overview of Therapy modalities and new developments in the treatment of prostate cancer 
E. Van Muilekom, NL

 17:50

Coffee break

 18:20 

Coaching: two groups  
A. Margulies, CH - S. Faithfull, UK - L. Sharp, SE - E. Van Muilekom, NL 

 20:30

Dinner

 

18 March

  8:30

Clinical session Breast cancer I
Chair: G. Curigliano, IT 

 
  • Pathology of breast cancer
    G. Pruneri, IT
  • Early systemic treatment I: Neoadjuvant 
    O. Pagani, CH
  • Early systemic treatment I: Neoadjuvant, surgical viewpoint
    W. Gatzemeier, IT
  • Early systemic treatment II: Adjuvant
    G. Curigliano, IT

 10:45

Coffee break

 11:15

New development in radiotherapy   
S. Faithfull, UK

 12:00

"Targeted" therapy - an introduction  
A. Margulies, CH

 12:15

Case studies presentation and discussion + plenary presentation 
Participants

 13:15

Lunch 

 14:30

Spotlight session 1 Haematological diseases
M. Ghielmini, CH

 15:30

Introduction to communication skills; Assessiong psychosocial health      
A. Hoy, UK - A. Arber, UK

 16:30

Coffee break 

 17:00

Communication skills cont.
A. Hoy, UK - A. Arber, UK

 19:30

Dinner 

 

19 March

   8:30

Communication skills workshopGroup 1 
A. Hoy, UK - A. Arber, UK 

   8:30

Clinical session Gynaecological cancers
Chair: J. Vermorken, BE

 

  • Ovarian cancer
    J.B. Vermorken, BE
  • Cervical and endometrial cancers
    C. Sessa, CH

 10:30

Coffee break

 11:00

Communication skills workshop - Group 2 
A. Hoy, UK - A. Arber, UK

 11:00

Clinical session Head and neck cancer
Chair: J. Bernier, CH

 

  • Prognostic factors and surgical approach
    A. Dietz, DE
  • Radiotherapy
    J. Bernier, CH
  • Systemic therapy
    J.B. Vermorken, BE

 13:00

Lunch

 14:30

Advanced Nursing Assessment skills
S. Faithfull, UK

 15:30

Research in clinical nursing
M. Wells, UK

 16:30

Spotlight session 3 Cancer and pregnancy 
N. Pavlidis, GR

 17:00

Coffee break

 17:30

10 min review gynaecology - Hand and neck sessions
Case study presentation and discussions + plenary presentation 
Participants

 19:30

Dinner 

 

20 March

  8:30

Clinical session Gastro-intestinal tumours I
Chair: E. Van Cutsem, BE

 

Colon cancer: 

  • Adjuvant and neoadjuvant treatment of colorectal cancer
    K.H. Köhne, DE
  • Systemic treatment in advanced disease                                      
    E. Van Cutsem, BE

 10:00

Sponsored lecture Metastasectomies in colorectal cancer
(SPCC lecture by Merk)
G.J. Poston, UK

 10:30

Coffee break

 11:00

Market place Sharpening your symptom management expertise 
 
  • Radiodematitis 
    M. Wells, UK
  • Skeletal events  
    E. Von Muilekom, NL
  • Skin toxicities and targeted therapy  
    A. Margulies, CH
  • Pelvic symptoms
    S. Faithfull, UK

  13:30 

Lunch  

 14:30

Sponsored lecture Maintenance treatment in advanced
non small cell lung cancer: a new treatment paradigm?
(SPCC lecture by Lilly)
T. Brodowicz, AT

 15:00 

e-Eso session on New accomplishments in breast cancer chemoprevention
A. Decensi
, Galliera Hospital, Genoa, IT

 16:00

Free afternoon

 19:30

Dinner

 

21 March

   8:30

Clinical session Lung cancer and mesothelioma I
Chair: R. Stahel, CH

 

  • Surgery
    W. Weder, CH
  • Radiotherapy
    C. Faivre-Finn, UK
  • Non-small cell lung cancer systemic therapy                                                                    
    R.A. Stahel, CH

 10:30

Coffee break

 11:00

Clinical session Lung cancer and mesothelioma II
Chair: R.A. Stahel, CH

 

  • Small cell lung cancer
    C. Faivre-Finn, UK
  • Mesothelioma
    R.A. Stahel, CH

 12:00

Case study presentation and discussions + plenary presentation 
Participants

 13:00

Lunch

 14:15

Joint medics and nursing session Side effects of systemic treatment and their management

 15:15

  • Cardiovascular toxicity
    A. Albini, IT
  • Skin toxicity
    S. Segaert, BE
  • Neurotoxicity
    G. Cavaletti, IT

 15:30

Joint medics and nursing session Oral therapy: Adherence, compliance and drug interaction
K. Redmond, CH

 16:00

Coffee break 

 16:30

Joint medics and nursing session Palliative care 

 
  • Pain control
    D. Schrijvers, BE
  • Advanced disease management
    A. Hoy, UK

 18:00

Learning assessment tests

 19:30

Dinner

 

22 March

   8:30

Survivorship and long term care planning
S. Faithfull, UK

   9:30

Developing your clinical practice  “Pictures speak louder than words”
A. Margulies, CH - S. Faithfull, UK - Participants

 10:30

Coffee break 
 11:00Presentation of results / Coaching Session
Participants
 12:00Closure